These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 8427708)
1. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro. Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708 [TBL] [Abstract][Full Text] [Related]
2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic characterization of muscarinic receptors of insect brains. Abdallah EA; Eldefrawi ME; Eldefrawi AT Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
5. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study. Tonnaer JA; Ernste BH; Wester J; Kelder K J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343 [TBL] [Abstract][Full Text] [Related]
6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
7. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA; Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes. Zhang LB; Horowitz B; Buxton IL Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444 [TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
10. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction. Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392 [TBL] [Abstract][Full Text] [Related]
11. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W; Wolfe BB Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies. Araujo DM; Lapchak PA; Quirion R Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129 [TBL] [Abstract][Full Text] [Related]
13. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649 [TBL] [Abstract][Full Text] [Related]
14. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [TBL] [Abstract][Full Text] [Related]
15. Characterization of muscarinic receptor subtypes on human peripheral lung. Casale TB; Ecklund P J Appl Physiol (1985); 1988 Aug; 65(2):594-600. PubMed ID: 3170410 [TBL] [Abstract][Full Text] [Related]
16. Regional binding of 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) to muscarinic receptors in rat brain and comparative analysis of minimum energy conformations. Collins D; Smith DA; Messer WS Neurochem Int; 1993 Mar; 22(3):237-47. PubMed ID: 8443567 [TBL] [Abstract][Full Text] [Related]
17. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
18. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Flynn DD; Mash DC Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852 [TBL] [Abstract][Full Text] [Related]
19. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
20. M1 and M3 muscarinic receptor subtypes in rat forebrain. Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]